Seegene USA

FREE WEBINAR: The Triple Threat: SARS-CoV-2, influenza, and respiratory syncytial virus - What's different this respiratory season? Distinguishing between the three can be challenging based on symptoms alone. Find out how this year's respiratory season compares to the last in this free webinar sponsored by Seegene USA, Inc.

The Triple Threat: Has it changed since the last respiratory season?
Register »https://register.gotowebinar.com/register/4457873573785581401?__hstc=17452326.075f1f6cbe841d7f78da81b5805b2ffc.1707425896521.1707425896521.1707425896521.1&__hssc=17452326.1.1707430387541&__hsfp=1361505549&hsCtaTracking=337828e6-d0e5-4dcc-aa94-89ea63ce7825%7C5d43cdd0-4350-4bc2-bad3-f3e714e065c5

Presented by industry expert J. Kristie Johnson, PhD, D(ABMM)
February 28, 2024 | Time: 10:00 AM - 11:00 AM PST | 1:00pm EST

www.linkedin.com

World Cancer Day is Sunday, February 4! 🌎
Cervical cancer: Every year, nearly 12,000 women living in the U.S. will have cervical cancer. More than 4,000 women die per year from cervical cancer.
Novaplex™ HPV28* are designed to identify 19 high-risk and/or 28 unique low and high-risk HPV types in a single specimen including those that are known to cause cervical cancer.
Novaplex™ HPV HR* is suitable for HPV testing in all circumstances, meeting diverse region-specific identification needs. It allows more efficient turnaround time and fully automated workflow and is designed to provide comprehensive information.
*All Novaplex™ products are for Research Use Only. Not for use in diagnostic procedures.
»Learn More https://seegeneus.com/assays/human-papillomavirus-infection-hpv/

Imagine a world free of diseases... A bold mission, right? 🌍🏥
Join us in supporting Dr. Jong Yoon Chun, CEO and founder of Seegene as they work towards making this vision a reality! 💪💉
Through the adoption of syndromic PCR molecular diagnostics and a partnership with Microsoft for digital transformation, they are revolutionizing the healthcare ecosystem and making a lasting impact. 🌟
»View Press Release
https://seegeneus.com/collaboration-with-microsoft/

👋 Did you get a chance to stop by Seegene's Booth # 2261 at and learn more about our exciting offers for AACC attendees this year?
Don't forget to take a look at our molecular testing solutions (including Research Use Only PCR assays for Monkeypox, Tick-Borne, Drug Resistance, UTI, STI, and more)!
https://seegenetech.com/2022-aacc-clinical-lab-expo/

Are you attending ?
✨We have some exciting offers for AACC attendees this year! ✨
Come by our Booth #2261 to learn more about our molecular testing solutions (including Research Use Only PCR assays for , Tick-Borne, Drug Resistance, UTI, STI, and more).
Learn more: https://seegenetech.com/2022-aacc-clinical-lab-expo/

Seegene develops PCR test* designed to detect monkeypox virus
Press Release: https://seegenetech.com/seegene-develops-pcr-test-to-detect-monkeypox-virus/

*Available in the US for Research Use Only. Not for use in Diagnostic Procedures.

Seegene develops PCR test to detect Monkeypox Virus – Seegene Technologies SEOUL, South Korea, June 28, 2022 /PRNewswire/ — Seegene Inc. (KQ965390), South Korea’s leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus. The Novaplex™ MPXV Assay, which specifically targets the monkeypox virus, was swiftly developed usin...

The surge in Sexually Transmitted Infections:
According to the CDC, 1,579,885 cases of Chlamydia trachomatis infection were reported in 2020 during the pandemic.
https://t.co/XhKrU0LyTE

Contact us to learn more about our Novaplex™ Research Use STI Assay: https://seegenetech.com/contact_us/

Sexually Transmitted Disease Surveillance, 2020 STD Information from CDC. Facts, Statistics, Treatment, and Other Resources.

Here is some useful information on from California Department of Public Health.

The Seegene Novaplex™ SARS-CoV-2 Variant Assay (Research Use Only) is designed to detect new and emerging SARS-CoV-2 variants, in a single tube.



Learn more here: https://seegenetech.com/novaplex-sars-cov-2-variants-ii-assay/

Our Novaplex™ SARS-CoV-2 Flu A/Flu B/RSV Assay (Research Use Only) is a multiplex real-time assay that allows researchers to amplify target nucleic acids for Influenza A virus, Influenza B virus, Human RSV and SARS-CoV-2 at the same time.

Learn more about the assay here:

https://seegenetech.com/novaplex_sars-cov-2_flua_flub_rsv_assay/

Are you attending the 2022 Annual Conference?
Come meet our Seegene Technologies team at Booth #500 to learn more about our multiplex molecular assays and automation solutions for your laboratory!
Learn more: https://seegenetech.com/2022-aphl-annual-conference/

A new CDC report shows among children ages 5–11 years hospitalized with COVID-19 during the first few months of , 30% had no underlying conditions, and 20% were admitted to the ICU.

Read more here:

Hospitalizations of Children Aged 5–11 Years with Laboratory... This report describes how unvaccinated children 5-11 years old were more likely to be hospitalized with COVID-19 than vaccinated children during initial Omicron predominance.

Our clients are using the Seegene STARlet to move their -19 ahead.

Learn more about how the Seegene STARlet helps to eliminate the overwhelm from your PCR workflows.

https://seegenetech.com/seegene-starlet/

Seegene STARlet – Seegene Technologies Seegene STARlet is an easy-to-use liquid handling workstation for handling primary sample tube to nucleic acid (NA) extraction and PCR setup. It provides a convenient process for your laboratory workflow by minimizing hands-on time and maximizing assay reliability.

Our in-silico analysis shows that our Allplex™ 2019-nCoV Assay is suitable for screening patients infected with the variants.

Learn more about the assay here: https://seegenetech.com/allplex_2019-ncov_assay/

Our Seegene Technologies team is exhibiting at the 2022 ASM Clinical Virology Symposium (ASM CVS) from May 1-4, 2022.
👉Stop by Booth #622 to learn more about our Research Use Only multiplex molecular assays!
Learn more here: https://bit.ly/3saolaf

An old one but still a good one.

Check out our case study on how CardioPath Laboratories used Seegene products to accurately detect bacterial pneumonia via PCR in a patient several days before pneumonia showed up on X-ray.

Early detection saves lives.

Read the case study here: http://ow.ly/3ghn50IXfAF

From Endless Assay Components to One Integrated Solution: A Case Study with CardioPath Laboratories – Seegene Technologies CardioPath Laboratories is a US-based comprehensive laboratory providing histology, immunohistochemistry, and molecular testing via endomyocardial biopsy using a simple, all-in-one approach. CardioPath also performs COVID-19 testing with a high-throughput capacity of 1,000 patient samples per day. C...

At-home testing for COVID-19 has been helpful in controlling the spread of the virus.

But there are pitfalls.

We discuss those pitfalls in our April blog.